Skip to main content
. 2017 Mar 17;13(5):3579–3585. doi: 10.3892/ol.2017.5872

Figure 1.

Figure 1.

Analysis of cell proliferation following treatment of prostate cancer cell lines with ARBs. A WST-1 assay was conducted to analyze cell viability. Cell viability was measured at 48 and 72 h in (A) PC3 and (B) DU145 cells or at 60 and 120 h in (C) LNCap-LN3 cells. Data are expressed as the mean ± standard deviation from 3 experiments with 3 replicates each. *P<0.05, **P<0.01, ***P<0.001. ARB, angiotensin II receptor blocker.